HRS4R
Vull donar

MONTSERRAT FERRER BATALLÉ

Personal d'Administració i Gestió
Firma
MONTSERRAT FERRER-BATALLÉ
Posició
Tècnica - Suport a direcció i gestió científica
Tècnica - Suport a direcció i gestió científica

Publicacions

Gratacós-Mulleras A, Duran A, Asadi Shehni A, Ferrer-Batallé M, Ramírez M, Comet J, De Llorens R, Saldova R, Llop E, Peracaula R

Characterisation of the main PSA glycoforms in aggressive prostate cancer.

SCIENTIFIC REPORTS, 2020, 10, 18974-18974 dx.doi.org/10.1038/s41598-020-75526-3

Llop E, Ferrer-Batallé M, Barrabés S, Guerrero PE, Ramírez M, Saldova R, Rudd PM, Aleixandre RN, Comet J, De Llorens R, Peracaula R

Erratum: Improvement of Prostate Cancer Diagnosis by Detecting PSA Glycosylation-Specific Changes: Erratum.

Theranostics, 2018, 8, 746-748 dx.doi.org/10.7150/thno.23906

Ferrer-Batallé M, Llop E, RAMIREZ MALAGON, JOSE MANUEL, Aleixandre RN, Saez M, Comet J, De Llorens R, Peracaula R

Comparative Study of Blood-Based Biomarkers, a2,3-Sialic Acid PSA and PHI, for High-Risk Prostate Cancer Detection.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 dx.doi.org/10.3390/ijms18040845

Barrabés S, Llop E, Ferrer-Batallé M, RAMIREZ MALAGON, JOSE MANUEL, Aleixandre RN, Perry AS, De Llorens R, Peracaula R

Analysis of urinary PSA glycosylation is not indicative of high-risk prostate cancer.

CLINICA CHIMICA ACTA, 2017, 470, 97-102 dx.doi.org/10.1016/j.cca.2017.05.009

Llop E, Ferrer-Batallé M, Barrabés S, Guerrero PE, Ramírez M, Saldova R, Rudd PM, Aleixandre RN, Comet J, De Llorens R, Peracaula R

Improvement of Prostate Cancer Diagnosis by Detecting PSA Glycosylation-Specific Changes.

Theranostics, 2016, 6, 1190-1204 dx.doi.org/10.7150/thno.15226

Panosa C, Tebar F, Ferrer-Batallé M, Fonge H, Seno M, Reilly RM, Massaguer A, De Llorens R

Development of an epidermal growth factor derivative with EGFR blocking activity.

Plos One, 2013, 8 dx.doi.org/10.1371/journal.pone.0069325

Formulari de contacte

Coneix l’IDIBGI!

menu